Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
(Edetate disodium + ethyl alcohol + minocycline hydrochloride) by Citius Pharmaceuticals for Pseudomonas aeruginosa Infections: Likelihood of Approval
(Edetate disodium + ethyl alcohol + minocycline hydrochloride) is under clinical development by Citius Pharmaceuticals and currently in Phase III...
(Edetate disodium + ethyl alcohol + minocycline hydrochloride) by Citius Pharmaceuticals for Staphylococcus aureus Infections: Likelihood of Approval
(Edetate disodium + ethyl alcohol + minocycline hydrochloride) is under clinical development by Citius Pharmaceuticals and currently in Phase III...
(Edetate disodium + ethyl alcohol + minocycline hydrochloride) by Citius Pharmaceuticals for Fungal Infections: Likelihood of Approval
(Edetate disodium + ethyl alcohol + minocycline hydrochloride) is under clinical development by Citius Pharmaceuticals and currently in Phase III...